惠泰医疗股价微跌0.45%，总经理拟减持不超过2%股份

Group 1 - The core viewpoint of the news is that Huatai Medical's stock price has experienced a slight decline, and the company is undergoing a significant share reduction by its vice chairman and general manager due to personal financial needs [1] - As of August 13, 2025, Huatai Medical's stock price is reported at 296.93 yuan, down 0.45% from the previous trading day, with a trading volume of 4.09 billion yuan and a turnover rate of 0.99% [1] - Huatai Medical operates in the medical device sector, focusing on the research, production, and sales of cardiac electrophysiology and interventional medical devices, making it a key player in the domestic market [1] Group 2 - The vice chairman and general manager, Cheng Zhenghui, plans to reduce his holdings by up to 2% of the total share capital, amounting to 282.03 million shares, with the reduction period set from September 3 to December 2, 2025 [1] - Recent developments in the medical consumables procurement process are ongoing, affecting high-value consumables such as inferior vena cava filters and ablation electrodes, which may alter the competitive landscape of the industry [1] - On August 13, 2025, Huatai Medical saw a net inflow of 743,900 yuan in main funds, with a cumulative net inflow of 11.39 million yuan over the past five days [2]